Part 1 – Central vs. Local Medication Sourcing
The randomization and trial supply management (RTSM) needs of clinical trials are complex. But, sponsors who leverage robust interactive response technology (IRT) systems can tackle the complexities – often without knowing they exist – in even the most complicated study designs, those involving oncology treatments.
There are many RTSM challenges in oncology trials, including the inherent unknowns regarding the number of visits each patient will complete, the need for different visit schedules per arm (as well as the difference between visits and cycles), and the topic we cover here: central vs local sourcing of standard-of-care treatments.